Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: July 30, 2015
Reporting Period: Second Quarter ended June 30, 2015
Context: This filing serves to distribute an Investor News release issued on July 29, 2015, containing second-quarter financial results. The registrant files annual reports under Form 20-F.
Key Financial Metrics
The Form 6-K text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references an attached Exhibit 99.1 (Investor News) which contains these figures.
- GAAP Measures: Consolidated financial results are presented in accordance with US GAAP in the attached exhibit.
- Non-GAAP Measures: The filing highlights the use of EBITDA (operating income excluding interest, taxes, depreciation, and amortization) and free cash flow to supplement GAAP results.
- Reconciliation: Reconciliations between non-GAAP and GAAP measures are located in the attached Investor News and Cash Flow Statement.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It states that non-GAAP measures are included to ensure consistency and comparability with prior periods for which these measures were previously reported.
Guidance, Outlook, and Risks
Management Commentary: Management asserts that the inclusion of non-GAAP measures enhances the user's understanding of current financial performance and future prospects. These measures are not intended to substitute for or be considered superior to GAAP measures.
Regulatory Note: The attached Investor News is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. It shall not be incorporated by reference in other filings.
Guidance/Risks: The text provided does not contain specific forward-looking guidance, risk factors, or details on contingencies.
Investor Verification Checklist
- Verify the specific numerical values for Q2 2015 revenue, EBITDA, and free cash flow in the attached Exhibit 99.1 (Investor News), as they are not present in the Form 6-K text.
- Review the reconciliation tables in the attached exhibit to understand the adjustments made to derive non-GAAP figures from GAAP results.
- Confirm the comparability of the reported non-GAAP measures against prior periods as claimed by management.
- Note that the financial data in the attached exhibit is not legally "filed" with the SEC under Section 18 of the Exchange Act.